{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:01:41Z","timestamp":1773889301272,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974030"],"award-info":[{"award-number":["81974030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.abb.2022.109217","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T20:37:43Z","timestamp":1649795863000},"page":"109217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Epigallocatechin-3-gallate exerts cardioprotective effects related to energy metabolism in pressure overload-induced cardiac dysfunction"],"prefix":"10.1016","volume":"723","author":[{"given":"Qiuhong","family":"Mou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongli","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xupei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.abb.2022.109217_bib1","doi-asserted-by":"crossref","first-page":"1900023","DOI":"10.1002\/advs.201900023","article-title":"Effective delivery of hypertrophic miRNA inhibitor by cholesterol-containing nanocarriers for preventing pressure overload induced cardiac hypertrophy","volume":"6","author":"Zhi","year":"2019","journal-title":"Adv. Sci."},{"issue":"10159","key":"10.1016\/j.abb.2022.109217_bib2","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.abb.2022.109217_bib3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.abb.2022.109217_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jama.292.3.344","article-title":"Trends in heart failure incidence and survival in a community-based population","volume":"292","author":"Roger","year":"2004","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.abb.2022.109217_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.lfs.2007.06.011","article-title":"Tea polyphenols for health promotion","volume":"81","author":"Khan","year":"2007","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.abb.2022.109217_bib6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/07388551.2020.1752617","article-title":"Exploring plant metabolic genomics: chemical diversity, metabolic complexity in the biosynthesis and transport of specialized metabolites with the tea plant as a model","volume":"40","author":"Zhao","year":"2020","journal-title":"Crit. Rev. Biotechnol."},{"issue":"12","key":"10.1016\/j.abb.2022.109217_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/nu12123792","article-title":"Possible reduction of cardiac risk after supplementation with epigallocatechin gallate and increase of ketone bodies in the blood in patients with multiple sclerosis. A pilot study","volume":"12","author":"Benlloch","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.abb.2022.109217_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12929-019-0528-7","article-title":"Green tea extract catechin improves cardiac function in pediatric cardiomyopathy patients with diastolic dysfunction","volume":"26","author":"Quan","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.abb.2022.109217_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.abb.2015.03.015","article-title":"Calcium desensitizer catechin reverses diastolic dysfunction in mice with restrictive cardiomyopathy","volume":"573","author":"Zhang","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.abb.2022.109217_bib10","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.biopha.2018.11.086","article-title":"Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate","volume":"109","author":"Al Hroob","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.abb.2022.109217_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/FJC.0000000000000545","article-title":"Ameliorative effect of epigallocatechin gallate on cardiac hypertrophy and fibrosis in aged rats","volume":"71","author":"Muhammed","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.abb.2022.109217_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13602","article-title":"EGCG inhibits pressure overload-induced cardiac hypertrophy via the PSMB5\/Nmnat2\/SIRT6-dependent signalling pathways","volume":"231","author":"Cai","year":"2021","journal-title":"Acta Physiol."},{"issue":"6928","key":"10.1016\/j.abb.2022.109217_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nature01510","article-title":"From genomics to proteomics","volume":"422","author":"Tyers","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.abb.2022.109217_bib14","doi-asserted-by":"crossref","first-page":"8684014","DOI":"10.1155\/2022\/8684014","article-title":"Butein inhibits oxidative stress injury in rats with chronic heart failure via ERK\/Nrf2 signaling","volume":"2022","author":"Liu","year":"2022","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.abb.2022.109217_bib15","doi-asserted-by":"crossref","first-page":"152845","DOI":"10.1016\/j.phymed.2019.152845","article-title":"Epigallocatechin gallate prevents mitochondrial impairment and cell apoptosis by regulating miR-30a\/p53 axis","volume":"61","author":"Zhang","year":"2019","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.abb.2022.109217_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.biopha.2007.10.011","article-title":"Protective effect of (-)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: a histopathological study","volume":"62","author":"Devika","year":"2008","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.abb.2022.109217_bib17","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.220871","article-title":"EGCG protects cardiomyocytes against hypoxia-reperfusion injury through inhibition of OMA1 activation","volume":"132","author":"Nan","year":"2019","journal-title":"J. Cell Sci."},{"issue":"1\u20132","key":"10.1016\/j.abb.2022.109217_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01076480","article-title":"Fatty acid-binding protein and its relation to fatty acid oxidation","volume":"123","author":"Veerkamp","year":"1993","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.abb.2022.109217_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.abb.2022.109217_bib20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbalip.2014.03.013","article-title":"Physiological regulation of lipoprotein lipase","volume":"1841","author":"Kersten","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.abb.2022.109217_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MOL.0000000000000676","article-title":"Regulation of lipoprotein lipase-mediated lipolysis of triglycerides","volume":"31","author":"Basu","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"issue":"3","key":"10.1016\/j.abb.2022.109217_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MOL.0000000000000297","article-title":"Role of lipoprotein lipase in lipid metabolism","volume":"27","author":"Olivecrona","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.abb.2022.109217_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yjmcc.2018.08.022","article-title":"Heart specific knockout of Ndufs4 ameliorates ischemia reperfusion injury","volume":"123","author":"Zhang","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.abb.2022.109217_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094157","article-title":"Complex I deficiency due to selective loss of Ndufs4 in the mouse heart results in severe hypertrophic cardiomyopathy","volume":"9","author":"Chouchani","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.abb.2022.109217_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cmet.2013.07.002","article-title":"Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure","volume":"18","author":"Karamanlidis","year":"2013","journal-title":"Cell Metabol."},{"issue":"8","key":"10.1016\/j.abb.2022.109217_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008170","article-title":"NAD(+) redox imbalance in the heart exacerbates diabetic cardiomyopathy","volume":"14","author":"Chiao","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"6165","key":"10.1016\/j.abb.2022.109217_bib27","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1244360","article-title":"mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome","volume":"342","author":"Johnson","year":"2013","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.abb.2022.109217_bib28","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.bcp.2011.03.009","article-title":"MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-kappaB\/TGFbeta1 pathway","volume":"81","author":"Ma","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.abb.2022.109217_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bcp.2012.10.025","article-title":"Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression","volume":"85","author":"Ma","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.abb.2022.109217_bib30","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1111\/jcmm.14308","article-title":"Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway","volume":"23","author":"Zeng","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.abb.2022.109217_bib31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/ajplegacy.1975.229.2.355","article-title":"Rat myocardial mechanics during pressure-induced hypertrophy development and reversal","volume":"229","author":"Jouannot","year":"1975","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.abb.2022.109217_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.abb.2014.08.007","article-title":"Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via inhibition of AMPK and activation of p38 MAPK signaling","volume":"562","author":"Wang","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.abb.2022.109217_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.abb.2018.01.006","article-title":"Baicalin inhibits pressure overload-induced cardiac fibrosis through regulating AMPK\/TGF-\u03b2\/Smads signaling pathway","volume":"640","author":"Xiao","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.abb.2022.109217_bib34","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.7150\/thno.38640","article-title":"Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1","volume":"10","author":"Wilhelmi","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.abb.2022.109217_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7150\/ijms.51133","article-title":"Neuropeptide Y mediates cardiac hypertrophy through microRNA-216b\/FoxO4 signaling pathway","volume":"18","author":"Wang","year":"2021","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.abb.2022.109217_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41401-020-0401-y","article-title":"Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPARalpha\/PGC-1 pathway","volume":"42","author":"Hou","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.abb.2022.109217_bib37","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.ijcard.2013.03.001","article-title":"Triptolide protects rat heart against pressure overload-induced cardiac fibrosis","volume":"168","author":"Zhang","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.abb.2022.109217_bib38","article-title":"Rutaecarpine ameliorates pressure overload cardiac hypertrophy by suppression of calcineurin and angiotensin II","volume":"2021","author":"Li","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.abb.2022.109217_bib39","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2147\/DDDT.S213910","article-title":"Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats","volume":"13","author":"Zheng","year":"2019","journal-title":"Drug Des. Dev. Ther."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986122001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986122001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:22:22Z","timestamp":1757744542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986122001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":39,"alternative-id":["S0003986122001023"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2022.109217","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin-3-gallate exerts cardioprotective effects related to energy metabolism in pressure overload-induced cardiac dysfunction","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2022.109217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109217"}}